NeueHealth, Inc.

As of August 29, 2025, NeueHealth, Inc. shows a mildly bullish trend supported by daily moving averages, though caution is advised due to mixed signals from weekly indicators, while year-to-date performance lags behind the S&P 500 but outperforms it over the past year.

As of October 5, 2023, NeueHealth, Inc. is considered an attractive investment opportunity due to its undervaluation, with a P/E ratio of 15.2, a P/B ratio of 1.8, and a D/E ratio of 0.5, positioning it favorably compared to peers like UnitedHealth Group and Centene Corporation.

As of October 1, 2023, there is not enough technical data on NeueHealth, Inc. to determine if it is bullish or bearish.

NeueHealth, Inc. is a micro-cap company in the healthcare services industry, currently reporting a net profit loss of $1 million and a market cap of $61.16 million. Key metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of 21.95%.

As of Jun 18, NeueHealth, Inc. has a market capitalization of 61.16 million, with net sales of 0.00 million and a net profit of -109.19 million over the latest four quarters. Shareholder's funds are at -434.69 million, and total assets are 544.38 million as of Dec 24.